179 related articles for article (PubMed ID: 37606993)
21. NerLTR-DTA: drug-target binding affinity prediction based on neighbor relationship and learning to rank.
Ru X; Ye X; Sakurai T; Zou Q
Bioinformatics; 2022 Mar; 38(7):1964-1971. PubMed ID: 35134828
[TBL] [Abstract][Full Text] [Related]
22. HyperAttentionDTI: improving drug-protein interaction prediction by sequence-based deep learning with attention mechanism.
Zhao Q; Zhao H; Zheng K; Wang J
Bioinformatics; 2022 Jan; 38(3):655-662. PubMed ID: 34664614
[TBL] [Abstract][Full Text] [Related]
23. Drug Response Prediction by Globally Capturing Drug and Cell Line Information in a Heterogeneous Network.
Le DH; Pham VH
J Mol Biol; 2018 Sep; 430(18 Pt A):2993-3004. PubMed ID: 29966608
[TBL] [Abstract][Full Text] [Related]
24. Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding.
Yuan Q; Chen K; Yu Y; Le NQK; Chua MCH
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36642410
[TBL] [Abstract][Full Text] [Related]
25. SPARSE: a sparse hypergraph neural network for learning multiple types of latent combinations to accurately predict drug-drug interactions.
Nguyen DA; Nguyen CH; Petschner P; Mamitsuka H
Bioinformatics; 2022 Jun; 38(Suppl 1):i333-i341. PubMed ID: 35758803
[TBL] [Abstract][Full Text] [Related]
26. Predicting adverse drug reactions through interpretable deep learning framework.
Dey S; Luo H; Fokoue A; Hu J; Zhang P
BMC Bioinformatics; 2018 Dec; 19(Suppl 21):476. PubMed ID: 30591036
[TBL] [Abstract][Full Text] [Related]
27. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
Emdadi A; Eslahchi C
J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
[TBL] [Abstract][Full Text] [Related]
28. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Potential Drug-Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features.
Xuan P; Song Y; Zhang T; Jia L
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443472
[TBL] [Abstract][Full Text] [Related]
30. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations.
Wang J; Liu X; Shen S; Deng L; Liu H
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34571537
[TBL] [Abstract][Full Text] [Related]
31. MHADTI: predicting drug-target interactions via multiview heterogeneous information network embedding with hierarchical attention mechanisms.
Tian Z; Peng X; Fang H; Zhang W; Dai Q; Ye Y
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36242566
[TBL] [Abstract][Full Text] [Related]
32. DeepSide: A Deep Learning Approach for Drug Side Effect Prediction.
Uner OC; Kuru HI; Cinbis RG; Tastan O; Cicek AE
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(1):330-339. PubMed ID: 34995191
[TBL] [Abstract][Full Text] [Related]
33. Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning.
Zhang Y; Qiu Y; Cui Y; Liu S; Zhang W
Methods; 2020 Jul; 179():37-46. PubMed ID: 32497603
[TBL] [Abstract][Full Text] [Related]
34. Fast and interpretable genomic data analysis using multiple approximate kernel learning.
Bektaş AB; Ak Ç; Gönen M
Bioinformatics; 2022 Jun; 38(Suppl 1):i77-i83. PubMed ID: 35758810
[TBL] [Abstract][Full Text] [Related]
35. Predicting drug-target interaction network using deep learning model.
You J; McLeod RD; Hu P
Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
[TBL] [Abstract][Full Text] [Related]
36. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
[TBL] [Abstract][Full Text] [Related]
37. DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions.
Liang Z; Huang JX; Zeng X; Zhang G
BMC Med Genomics; 2016 Aug; 9 Suppl 2(Suppl 2):48. PubMed ID: 27510822
[TBL] [Abstract][Full Text] [Related]
38. In silico drug repositioning using deep learning and comprehensive similarity measures.
Yi HC; You ZH; Wang L; Su XR; Zhou X; Jiang TH
BMC Bioinformatics; 2021 Jun; 22(Suppl 3):293. PubMed ID: 34074242
[TBL] [Abstract][Full Text] [Related]
39. Identifying drug-target interactions based on graph convolutional network and deep neural network.
Zhao T; Hu Y; Valsdottir LR; Zang T; Peng J
Brief Bioinform; 2021 Mar; 22(2):2141-2150. PubMed ID: 32367110
[TBL] [Abstract][Full Text] [Related]
40. DeepIDC: A Prediction Framework of Injectable Drug Combination Based on Heterogeneous Information and Deep Learning.
Yang Y; Gao D; Xie X; Qin J; Li J; Lin H; Yan D; Deng K
Clin Pharmacokinet; 2022 Dec; 61(12):1749-1759. PubMed ID: 36369328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
